tiprankstipranks

Jon Stonehouse Insider Profile

11 Followers
Jon Stonehouse, President & CEO, Director at BioCryst, holds 1.17M shares in BioCryst (Ticker: BCRX), holds 204.09K shares in Bellicum Pharmaceuticals (Ticker: BLCM). Most recently, Jon Stonehouse Bought ― shares of BioCryst on May 15, 2024 for an estimated value of 166.50K.
tipranks
Jon Stonehouse

Jon Stonehouse
BioCryst (BCRX)
President & CEO, Director

Ranked #22,855 out of 98,042 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+27.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$8M
100.00%
A breakdown of Jon Stonehouse's holdings

Insider Roles

BioCryst
(BCRX)
President & CEO, Director
Roles that Jon Stonehouse holds in companies

Most Profitable Insider Trade

Stock:
BioCryst
(BCRX)
Rating:Informative Buy
Date:Nov 18, 2019 - Nov 18, 2020
Return:+151.70%
The most profitable trade made by Jon Stonehouse

Jon Stonehouse's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BioCryst
May 15, 2024
President & CEO, Director
Informative Buy
166.50K
$8.34M
BLCM
Bellicum Pharmaceuticals
Nov 13, 2018
Informative Buy
45.60K
$15.10K
List of latest transactions for each holding click on a transaction to see Jon Stonehouse's performance on stock

Jon Stonehouse insider profile FAQ

What is the percentage of profitable transactions made by Jon Stonehouse?
The percentage of profitable transactions made by Jon Stonehouse is 67%.
    What is the average return per transaction made by Jon Stonehouse?
    The average return per transaction made by Jon Stonehouse is 27.80%.
      What stocks does Jon Stonehouse hold?
      Jon Stonehouse holds: BCRX, BLCM stocks.
        What was Jon Stonehouse’s latest transaction?
        Jon Stonehouse latest transaction was an Informative Buy of $166.50K.
          What was Jon Stonehouse's most profitable transaction?
          Jon Stonehouse’s most profitable transaction was an Informative Buy of BCRX stock on November 18, 2019. The return on the trade was 151.70%.
            What is Jon Stonehouse's role in BioCryst?
            Jon Stonehouse's role in BioCryst is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.